Format

Send to

Choose Destination
Am J Infect Control. 2008 Nov;36(9):627-37. doi: 10.1016/j.ajic.2008.03.003. Epub 2008 Oct 3.

International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008.

Collaborators (190)

Guzmán S, Alcaraz Mdel C, Boglione A, Migone O, Toledo JC, Forciniti S, Gilli M, Blasco M, Lezcano LC, Sztokhamer D, Di Núbila BM, Quevedo H, Lanzetta D, Fernández LJ, Romani A, Migazz C, Barolin C, Viegas M, Soroka LC, Santoro B, Lastra CE, Flynn LP, Rausch D, Spagnolo A, Frías ML, Churruarín G, Kobylarz A, Salomao R, Blecher S, da Silva MA, Vilins M, da Silva EH, Grinberg G, Ferreira IB, Nouer S, Vianna R, Machado AL, Gama E, Blanquet D, Spessatto JL, Pasini RS, Ferla S, Zanandrea BB, Rohnkohl C, Regalin M, Angelieri DB, Linares C, Osorio L, Gómez WV, Vergara GR, Pertuz AM, Sussmann O, Mojica BE, Olarte N, Valderrama A, Agudelo JG, Rojas C, Beltran H, Paez J, Navarrete Mdel P, Calderón ME, Ferrer MR, Guzmán NB, Villa GS, Guzmán AL, Calzada JM, Muñoz G, Argüello AR, Pérez CM, de Casares AC, Machuca Lde J, Karlekar A, Kapoor P, Pawar M, Trehan N, Todi SK, Chakraborty P, Chatterjee S, Rodrigues C, Hegde A, Singhal T, Chakravarthy M, Jawali V, Venkatachalam N, Sen N, Raj JP, Sahu S, Bindhani D, Ramachandran B, Singh S, Krishnakumar S, Ravindran K, Nainan Myatra S, Divatia JV, Kelka R, Biswas S, Singhal H, Raut S, Mahale N, Dhakate V, Sampat S, Gopinath R, Ravindra N, Baftiu N, Spahija G, Kanj-Sharara N, Nisreen S, Jurdi LA, Anguseva T, Ampova V, Oropeza MS, Bravo Ml, Franc G, Ruiz J, Duarte P, Hernández HT, Gómez AC, Morales JR, Rodrígues JE, Serrato IP, López MS, Ruiz AA, Campuzano, Brito JM, Abouqal R, Zeggwagh AA, Abidi K, Dutse AI, Habib Al, Rosa Rosales R, Bravo LI, Cáceres ML, Maldonado EF, Espichan MJ, Cárdenas YG, Sabogal AC, Cosavalente LC, Rodrguez T, Goicochea IP, Espinoza TA, Luna GJ, López FS, Asetre-Luna I, Yu C, Berba R, Angelo S Genuino G, Consunji RJ, Mantaring JB 3rd, Ozgültekin A, Turan G, Akgün N, Yalcin AN, Turhan O, Keskin S, Akan OA, Tulunay M, Oral M, Unal N, Koksal I, Yylmaz G, Senel AC, Sözen EE, Erben N, Ozgúnes I, Usluer G, Esen S, Ulger F, Aygun C, Kücxüködük S, Sirmatel F, Cengiz M, Yilmaz L, Sardan YC, Yildirim G, Topeli A, Alp E, Aygen B, Ozdemir D, Erdogan NS, Ulusoy S, Arda B, Bacakoglu F, Turgut H, Sacar S, Okke D, Oztürk R, Dikmen Y, Aygún G, Ottonelli A, De León G.

Author information

1
Medical College of Buenos Aires and Bernal Medical Center, Buenos Aires, Argentina. victor_rosenthal@inicc.org

Abstract

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from 2002 through 2007 in 98 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study, using Centers for Disease Control and Prevention (CDC) National Nosocomial Infections Surveillance System (NNIS) definitions for device-associated health care-associated infection, we collected prospective data from 43,114 patients hospitalized in the Consortium's hospital ICUs for an aggregate of 272,279 days. Although device utilization in the INICC ICUs was remarkably similar to that reported from US ICUs in the CDC's National Healthcare Safety Network, rates of device-associated nosocomial infection were markedly higher in the ICUs of the INICC hospitals: the pooled rate of central line-associated bloodstream infections (CLABs) in the INICC ICUs, 9.2 per 1000 CL-days, is nearly 3-fold higher than the 2.4-5.3 per 1000 CL-days reported from comparable US ICUs, and the overall rate of ventilator-associated pneumonia was also far higher, 19.5 vs 1.1-3.6 per 1000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 6.5 versus 3.4-5.2 per 1000 catheter-days. Most strikingly, the frequencies of resistance of Staphylococcus aureus isolates to methicillin (MRSA) (80.8% vs 48.1%), Enterobacter species to ceftriaxone (50.8% vs 17.8%), and Pseudomonas aeruginosa to fluoroquinolones (52.4% vs 29.1%) were also far higher in the Consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 14.3% (CLABs) to 27.5% (ventilator-associated pneumonia).

PMID:
18834725
DOI:
10.1016/j.ajic.2008.03.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center